» Articles » PMID: 25368979

Circadian Rhythm of Circulating Levels of the Endocannabinoid 2-arachidonoylglycerol

Overview
Specialty Endocrinology
Date 2014 Nov 5
PMID 25368979
Citations 41
Authors
Affiliations
Soon will be listed here.
Abstract

Context: The endocannabinoid (eCB) system is involved in the regulation of food intake and of peripheral metabolism. Although the cross talk between energy metabolism and the circadian system is well documented, little is known about a potential circadian modulation of human eCB activity.

Objective: The objective of the study was to define the 24-hour profile of circulating levels of the most abundant endogenous ligand of the CB1 receptor, 2-arachidonoylglycerol (2-AG), in healthy young nonobese adults studied under controlled bedtime, dietary, and activity conditions.

Methods: Fourteen subjects participated in this 4-day laboratory study with fixed light-dark cycles, standardized meals, and bedtimes. Sleep was recorded each night. On the third day, blood sampling at 15- to 30-minute intervals began at 9:30 pm and continued for 24 hours. Cortisol, leptin, and ghrelin were assayed on all samples, whereas the levels of 2-AG and its structural analog, 2-oleoylglycerol (2-OG), were measured at 60-minute intervals.

Results: All participants exhibited a large circadian variation of 2-AG serum concentrations with a nadir around midsleep, coincident with the middle of the overnight fast. Levels of 2-AG increased continually across the morning, peaking in the early to midafternoon. Peak values represented, on average, a nearly 3-fold increase above nocturnal nadir levels. Concentrations of 2-OG followed a similar pattern, although with a shorter morning increase and lower amplitude.

Conclusions: The findings demonstrate that activity of the eCB system is profoundly modulated by circadian rhythmicity and suggest that its impact on the regulation of food intake is suppressed during sleep and is maximal during early to midafternoon.

Citing Articles

Cannabinoids-Multifunctional Compounds, Applications and Challenges-Mini Review.

Duczmal D, Bazan-Wozniak A, Niedzielska K, Pietrzak R Molecules. 2024; 29(20).

PMID: 39459291 PMC: 11510081. DOI: 10.3390/molecules29204923.


Comparative targeted lipidomics between serum and cerebrospinal fluid of multiple sclerosis patients shows sex and age-specific differences of endocannabinoids and glucocorticoids.

Meier P, Glasmacher S, Salmen A, Chan A, Gertsch J Acta Neuropathol Commun. 2024; 12(1):160.

PMID: 39385315 PMC: 11465707. DOI: 10.1186/s40478-024-01864-2.


Peripheral endocannabinoids in major depressive disorder and alcohol use disorder: a systematic review.

Fuentes J, Mayans J, Guarro M, Canosa I, Mestre-Pinto J, Fonseca F BMC Psychiatry. 2024; 24(1):551.

PMID: 39118031 PMC: 11308641. DOI: 10.1186/s12888-024-05986-8.


The circulating and central endocannabinoid system in obesity and weight loss.

Mattelaer N, Van der Schueren B, Van Oudenhove L, Weltens N, Vangoitsenhoven R Int J Obes (Lond). 2024; 48(10):1363-1382.

PMID: 38834796 DOI: 10.1038/s41366-024-01553-z.


Hair cortisol and endocannabinoid measurement in patients with adrenal incidentalomas: a case-control study.

Mytareli C, Athanasouli F, Andreadaki E, Thanasoula F, Angelousi A Hormones (Athens). 2023; 23(1):113-120.

PMID: 37792214 DOI: 10.1007/s42000-023-00495-x.


References
1.
Kirkham T, Williams C, Fezza F, Di Marzo V . Endocannabinoid levels in rat limbic forebrain and hypothalamus in relation to fasting, feeding and satiation: stimulation of eating by 2-arachidonoyl glycerol. Br J Pharmacol. 2002; 136(4):550-7. PMC: 1573386. DOI: 10.1038/sj.bjp.0704767. View

2.
Bass J, Takahashi J . Circadian integration of metabolism and energetics. Science. 2010; 330(6009):1349-54. PMC: 3756146. DOI: 10.1126/science.1195027. View

3.
Arble D, Bass J, Laposky A, Vitaterna M, Turek F . Circadian timing of food intake contributes to weight gain. Obesity (Silver Spring). 2009; 17(11):2100-2. PMC: 3499064. DOI: 10.1038/oby.2009.264. View

4.
Rueda-Orozco P, Soria-Gomez E, Montes-Rodriguez C, Martinez-Vargas M, Galicia O, Navarro L . A potential function of endocannabinoids in the selection of a navigation strategy by rats. Psychopharmacology (Berl). 2007; 198(4):565-76. DOI: 10.1007/s00213-007-0911-z. View

5.
Kleberg K, Hassing H, Hansen H . Classical endocannabinoid-like compounds and their regulation by nutrients. Biofactors. 2014; 40(4):363-72. DOI: 10.1002/biof.1158. View